Human Genome Sciences (HGSI1)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
CEO:
Employees:
14200 SHADY GROVE ROAD, ROCKVILLE, MD 20850-3338
3013098504

*** This stock is shown as delisted in our database. *** If you think this isn't correct then please let us know

N/A

Data derived from most recent annual or quarterly report
Market Cap 2.829 Billion Shares Outstanding198.66 Million Avg 30-day Volume 11.975 Million
P/E Ratio0.0 Dividend Yield0.0 EPS-1.79
Price to Revenue14.0407 Debt to Equity2.7584 EBITDA-246.256 Million
Price to Book Value8.7338 Operating Margin-158.5085 Enterprise Value2.701 Billion
Current Ratio1.791 EPS Growth0 Quick Ratio1.593
1 Yr BETA 0.8928 52-week High/Low 0.0 / Profit Margin-190.2248
Operating Cash Flow Growth20.8389 Altman Z-Score-2.0332 Free Cash Flow to Firm -245.733 Million
View SEC Filings from HGSI1 instead.

View recent insider trading info

Funds Holding HGSI1 (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding HGSI1 BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

GLAXOSMITHKLINE PLC

  • Director
  • 10% Owner
233,716,708 2012-08-01 0

MORROW GEORGE J

  • Director
No longer subject to file 2012-07-30 0

KARABELAS ARGERIS N

  • Director
0 2012-07-30 0

DAVIS JAMES H EXEC. VP, GEN COUNSEL & SEC.

  • Officer
No longer subject to file 2012-07-30 0

BATESON SUSAN D. SENIOR VICE PRESIDENT

  • Officer
No longer subject to file 2012-07-30 0

STUMP DAVID C EXEC. VICE PRESIDENT

  • Officer
No longer subject to file 2012-07-30 0

DANZIG RICHARD J

  • Director
No longer subject to file 2012-07-30 0

YOUNG ROBERT C

  • Director
No longer subject to file 2012-07-30 0

LAMATTINA JOHN L

  • Director
No longer subject to file 2012-07-30 0

GODDARD COLIN

  • Director
No longer subject to file 2012-07-30 0

HA NGOC TUAN

  • Director
No longer subject to file 2012-07-30 0

SOUTHWELL DAVID P CHIEF FINANCIAL OFFICER

  • Officer
No longer subject to file 2012-07-30 0

LAWLOR AUGUSTINE

  • Director
0 2012-07-30 0

GOWEN MAXINE

  • Director
No longer subject to file 2012-07-30 0

CONNELLY DEIRDRE P PRESIDENT & CEO

  • Officer
  • Director
0 2012-07-30 0

LABINGER BARRY EXEC VP & CCO

  • Officer
No longer subject to file 2012-07-30 0

SIMPSON CURRAN SR. VP, OPERATIONS

  • Officer
No longer subject to file 2012-07-30 0

NORDEN GREGORY

  • Director
0 2012-07-30 0

BAXTER ALLAN

  • Director
No longer subject to file 2012-07-30 0

PARKER CRAIG C SR VP STRATEGY AND CORPORATE D

  • Officer
No longer subject to file 2012-07-30 0

CONNOR ROGER

  • Director
0 2012-07-30 0

TOMLINSON IAN

  • Director
0 2012-07-30 0

REDFERN DAVID

  • Director
0 2012-07-30 0

KOCZYNSKI CHESTER

  • Director
0 2012-07-30 0

TROY DANIEL SECRETARY

  • Officer
  • Director
0 2012-07-30 0

RAWCLIFFE ADRIAN CHIEF FINANCIAL OFFICER

  • Officer
  • Director
0 2012-07-30 0

WATKINS THOMAS CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
No longer subject to file 2012-07-25 0

DREWS JURGEN

  • Director
10,835 2011-01-10 0

BARABE TIMOTHY C CHIEF FINANCIAL OFFICER

  • Officer
49,571 2010-02-22 0

LINK MAX

  • Director
27,699 2008-04-11 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments